Northern Trust’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Northern Trust’s Portfolio PRNB Stock Details PRNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-359,466	Closed	-$21.5M	–	4339
2020 Q2	$21.5M	Buy	359,466 +115,326	+47%	+$7.12M	0.01%	1556
2020 Q1	$14.5M	Buy	244,140 +3,382	+1%	+$197K	﹤0.01%	1628
2019 Q4	$13.2M	Buy	240,758 +77,329	+47%	+$2.89M	﹤0.01%	1999
2019 Q3	$4.62M	Buy	163,429 +74,795	+84%	+$2.74M	﹤0.01%	2596
2019 Q2	$2.94M	Buy	88,634 +7,169	+9%	+$224K	﹤0.01%	2849
2019 Q1	$2.77M	Buy	81,465 +601	+0.7%	+$19.1K	﹤0.01%	2890
2018 Q4	$2.21M	Buy	80,864 +70,511	+681%	+$1.82M	﹤0.01%	2989
2018 Q3	$303K	Buy	+10,353	New	+$292K	﹤0.01%	3760

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return

Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ADL

Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Northern Trust's PRNB Position: Q3 2020 in Review

Northern Trust sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 359,466 shares — an estimated $21.5M sold.

Northern Trust first reported a position in PRNB in Q3 2018 and held it in 8 quarters. The position peaked at $21.5M in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

Northern Trust reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Northern Trust sold 359,466 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $21.5M.
Northern Trust first reported a position in Principia Biopharma Inc. Common Stock in Q3 2018 and held it in 8 quarters.
Northern Trust's Principia Biopharma Inc. Common Stock position peaked at $21.5M in Q2 2020.
9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Northern Trust's 13F filing for Q3 2020, filed 16 Nov 2020.